Mesoblast Limited (ASX:MSB) In Strong Cash Position At End Of Financial Year
Australian regenerative medicine company, Mesoblast Limited (ASX:MSB)(PINK:MBLTY), today announced that its cash position at 30 June 2009 was A$16.5 million.
Companies in the News
Biotech
Mesoblast Limited (ASX:MSB) Letter To Shareholders From Chairman, Brian Jamieson
Mesoblast Limited (ASX:MSB)(PINK:MBLTY) has entered the new financial year with sufficient cash reserves to meet its near-term clinical and commercial objectives. With A$16.5 million cash in hand at the end of June 2009, we can maintain the brisk pace of product development that has been the hallmark of your company since its public listing just 4.5 years ago.
Benitec Limited (ASX:BLT) US Re-Exam Update
The Directors of Benitec Limited (ASX:BLT)(PINK:BNIKF) provide the following update on the US patent Ex Parte reexamination on the Graham '099 patent (90/007,247). On 22 May 2009, a Notice of Appeal was filed with the USPTO. As part of the appeal process, an Appeal Brief was filed yesterday in response to the Examiner's final rejection in the Final Office action dated 26 November 2008.
Mesoblast Limited (ASX:MSB) Applies For Regulatory Approval Of Its Bone Fracture Repair Products
Australian regenerative medicine company, Mesoblast Limited (ASX:MSB)(PINK:MBLTY), today announced that it had commenced a formal process aimed at obtaining licenses from the Therapeutic Goods Administration (TGA) to commercially manufacture and distribute its adult stem cell products in Australia.
Benitec Limited (ASX:BLT) Signs Memorandum Of Understanding With Biomics Biotechnologies Co. Ltd In China
Benitec Limited (ASX:BLT)(PINK:BNIKF) has signed a Memorandum of Understanding with China based Biomics Biotechnologies Co. Ltd. The companies will collaborate on a DNA directed or vector expressed RNAi for the treatment of chronic hepatitis B virus (HBV) infection.
iSOFT Group Limited (ASX:ISF) Appoints Dr. James Fox As Non-Executive Director
iSOFT Group Limited (ASX:ISF) Australia's largest listed health information technology company today announced the appointment of Dr. James (Jim) Fox as Non-Executive Director, as iSOFT seeks to increase the number of independent directors on its Board.
Mesoblast Limited's (ASX:MSB) First Patients In Bone Marrow Transplant Trial Show Earlier Engraftment
Australian regenerative medicine company Mesoblast Limited (ASX:MSB)(PINK:MBLTY) today announced successful results from the first five patients who underwent bone marrow transplantation with haematopoietic stem and progenitor cells expanded by the patented allogeneic, or "off-the-shelf", Mesenchymal Precursor Cells (MPCs).
◂Previous Page
Biotech Next Page▸
Banking & Finance
- VIDEO: Lion Selection Group Ltd (ASX:LSX) CEO Hedley Widdup and Sean Russo Talk at the Australian Gold Conference 2024
- VIDEO: The Australian Gold Conference 2024 - Education Evening with Expert Panel
- Lithium Universe Ltd (ASX:LU7) Finalises Frankfurt and US OTC Listing
- ISX Financial Reports Strong Q2 2024 Results, Highlighting Robust Growth and Innovation
- NSX Limited (ASX:NSX) Company Update
- ASIC vs iSignthis Ltd and Nickolas John Karantzis
Oil Gas & Energy
- Central Petroleum Limited (ASX:CTP) Live Online Investor Presentation
- State Gas Limited (ASX:GAS) Quarterly Activities Report
- Beetaloo Energy Australia Limited (ASX:BTL) Quarterly Activities Report - 30 June
- Basin Energy Ltd (ASX:BSN) Quarterly Activities Report
- Central Petroleum Limited (ASX:CTP) Share Buy-Back
- Central Petroleum Limited (ASX:CTP) Quarterly Activities Report
Life Sciences
- Ellis Martin Report: Redefining Cancer Treatment - RenovoRx, Inc. (NASDAQ:RNXT) CEO Shaun Bagai on Targeted Pancreatic Therapy
- BPH Energy Limited (ASX:BPH) Quarterly Activities Report
- Proteomics International Laboratories Ltd (ASX:PIQ) Quarterly Activities/Appendix 4C Cash Flow Report
- Proteomics International Laboratories Ltd (ASX:PIQ) Next-Gen PromarkerD Test Performance Results Published
- Proteomics International Laboratories Ltd (ASX:PIQ) OxiDx Test Detects Muscle Damage in Thoroughbred Racehorses
- Proteomics International Laboratories Ltd (ASX:PIQ) AMA Grants Reimbursement Code for Next-Gen PromarkerD Test
Social Media
